← Evidence map

ReviewJBMR plus2021

The role of bone-modifying agents in myeloma bone disease.

Huifang Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34368608